James S. Farrelly, MD, MHS
Assistant Professor of Surgery (General, Trauma & Surgical Critical Care)
Research & Publications
Biography
Research Summary
Minimally Invasive Fetal Therapy, Myelomeningocele/Spina Bifida, Healthcare Inefficiency
Coauthors
Selected Publications
- Alginate microparticles loaded with basic fibroblast growth factor induce tissue coverage in a rat model of myelomeningoceleFarrelly JS, Bianchi AH, Ricciardi AS, Buzzelli GL, Ahle SL, Freedman-Weiss MR, Luks VL, Saltzman WM, Stitelman DH. Alginate microparticles loaded with basic fibroblast growth factor induce tissue coverage in a rat model of myelomeningocele. Journal Of Pediatric Surgery 2018, 54: 80-85. PMID: 30414695, DOI: 10.1016/j.jpedsurg.2018.10.031.
- In utero nanoparticle delivery for site-specific genome editingRicciardi AS, Bahal R, Farrelly JS, Quijano E, Bianchi AH, Luks VL, Putman R, López-Giráldez F, Coşkun S, Song E, Liu Y, Hsieh WC, Ly DH, Stitelman DH, Glazer PM, Saltzman WM. In utero nanoparticle delivery for site-specific genome editing. Nature Communications 2018, 9: 2481. PMID: 29946143, PMCID: PMC6018676, DOI: 10.1038/s41467-018-04894-2.
- Surgical tray optimization as a simple means to decrease perioperative costsFarrelly JS, Clemons C, Witkins S, Hall W, Christison-Lagay ER, Ozgediz DE, Cowles RA, Stitelman DH, Caty MG. Surgical tray optimization as a simple means to decrease perioperative costs. Journal Of Surgical Research 2017, 220: 320-326. PMID: 29180198, DOI: 10.1016/j.jss.2017.06.029.
- Complications in pediatric enteral and vascular accessFarrelly JS, Stitelman DH. Complications in pediatric enteral and vascular access. Seminars In Pediatric Surgery 2016, 25: 371-379. PMID: 27989361, DOI: 10.1053/j.sempedsurg.2016.10.006.
- Acquired seminal vesicle cyst in a teenager with a urethral stricture of unknown etiologyFarrelly JS, Cleary MA, Weiss RM, Morotti R, Stitelman DH. Acquired seminal vesicle cyst in a teenager with a urethral stricture of unknown etiology. Journal of Pediatric Surgery Case Reports. Volume 7, Pages 1-50 (April 2016)
- A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer.Morris MJ, Eisenberger MA, Pili R, Denmeade SR, Rathkopf D, Slovin SF, Farrelly J, Chudow JJ, Vincent M, Scher HI, Carducci MA. A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2012, 23: 2714-9. PMID: 22553195, PMCID: PMC3457748, DOI: 10.1093/annonc/mds078.